##fileformat=VCFv4.2
##reference=chrM.fa
##contig=<ID=chrM,length=16569>
##INFO=<ID=MITOMAP_Disease,Number=1,Type=String,Description="MITOMAP_Disease">
##INFO=<ID=MITOMAP_Status,Number=1,Type=String,Description="MITOMAP_Status">
##INFO=<ID=MITOMAP_Update,Number=1,Type=String,Description="MITOMAP_Update">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chrM	583	.	G	A	.	.	MITOMAP_Disease="MELAS MM & EXIT";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.10.10"
chrM	616	.	T	C	.	.	MITOMAP_Disease="Maternally inherited epilepsy mito tubulointerstitial kidney disease (MITKD) Gitelman-like syndrome";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.13"
chrM	1494	.	C	T	.	.	MITOMAP_Disease="DEAF";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.27"
chrM	1555	rs267606617	A	G	.	.	MITOMAP_Disease="DEAF, autism spectrum intellectual disability, possibly antiatherosclerotic";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.12.15"
chrM	1606	.	G	A	.	.	MITOMAP_Disease="AMDF";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	1630	.	A	G	.	.	MITOMAP_Disease="MNGIE-like disease MELAS";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.11.14"
chrM	1644	.	G	A	.	.	MITOMAP_Disease="Leigh Syndrome HCM MELAS";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2020.08.20"
chrM	3243	rs199474657	A	G	.	.	MITOMAP_Disease="MELAS Leigh Syndrome DMDF MIDD SNHL CPEO MM FSGS ASD Cardiac+multi-organ dysfunction";MITOMAP_Status="Cfrm P";MITOMAP_Update="2020.07.29"
chrM	3243	.	A	T	.	.	MITOMAP_Disease="MM MELAS SNHL CPEO";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.10.10"
chrM	3256	.	C	T	.	.	MITOMAP_Disease="MELAS, possible atherosclerosis risk";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.18"
chrM	3258	.	T	C	.	.	MITOMAP_Disease="MELAS Myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.08"
chrM	3260	.	A	G	.	.	MITOMAP_Disease="MMC MELAS";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.22"
chrM	3271	.	T	C	.	.	MITOMAP_Disease="MELAS DM MERRF-like";MITOMAP_Status="Cfrm P";MITOMAP_Update="2023.04.25"
chrM	3272	.	TT	T	.	.	MITOMAP_Disease="PEM retinal dystrophy in MELAS";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2023.05.23"
chrM	3280	.	A	G	.	.	MITOMAP_Disease="Myopathy";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.23"
chrM	3291	.	T	C	.	.	MITOMAP_Disease="MELAS Myopathy Deafness+Cognitive Impairment";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.10.03"
chrM	3302	.	A	G	.	.	MITOMAP_Disease="MM";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.18"
chrM	3303	.	C	T	.	.	MITOMAP_Disease="MMC";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.01.09"
chrM	3376	.	G	A	.	.	MITOMAP_Disease="LHON MELAS overlap";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	3460	rs199476118	G	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm P";MITOMAP_Update="2023.04.25"
chrM	3481	.	G	A	.	.	MITOMAP_Disease="MELAS Progressive Encephalomyopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.09.26"
chrM	3635	.	G	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.23"
chrM	3688	.	G	A	.	.	MITOMAP_Disease="Leigh Syndrome";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.12.21"
chrM	3697	.	G	A	.	.	MITOMAP_Disease="MELAS Leigh Syndrome LDYT BSN";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	3700	.	G	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.04.13"
chrM	3733	.	G	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	3890	.	G	A	.	.	MITOMAP_Disease="Progressive Encephalomyopathy Leigh Syndrome Optic Atrophy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	3902	.	ACCTTGC	GCAAGGT	.	.	MITOMAP_Disease="EXIT+myalgia severe LA+cardiac 3-MGA aciduria nephropathy+deafness+diabetes";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	4171	.	C	A	.	.	MITOMAP_Disease="LHON Leigh-like phenotype";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	4298	.	G	A	.	.	MITOMAP_Disease="CPEO MS";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.12.12"
chrM	4300	.	A	G	.	.	MITOMAP_Disease="MICM";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.18"
chrM	4308	.	G	A	.	.	MITOMAP_Disease="CPEO";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.10.10"
chrM	4332	.	G	A	.	.	MITOMAP_Disease="Encephalopathy MELAS";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2023.01.23"
chrM	4450	.	G	A	.	.	MITOMAP_Disease="Myopathy MELAS Leigh Syndrome EXIT";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.02.27"
chrM	4810	.	G	A	.	.	MITOMAP_Disease="EXIT with myalgia & ophthalmoplegia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.10.09"
chrM	5521	.	G	A	.	.	MITOMAP_Disease="Mitochondrial myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.10.03"
chrM	5537	.	A	AT	.	.	MITOMAP_Disease="Leigh Syndrome";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.23"
chrM	5650	.	G	A	.	.	MITOMAP_Disease="Myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.10.24"
chrM	5690	.	A	G	.	.	MITOMAP_Disease="CPEO+ptosis+proximal myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.01.09"
chrM	5703	.	G	A	.	.	MITOMAP_Disease="CPEO MM";MITOMAP_Status="Cfrm P";MITOMAP_Update="2023.02.13"
chrM	5728	.	T	C	.	.	MITOMAP_Disease="Multiorgan failure myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.02.13"
chrM	5920	.	G	A	.	.	MITOMAP_Disease="Myoglobinuria EXIT";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2024.01.22"
chrM	6930	.	G	A	.	.	MITOMAP_Disease="Multisystem Disorder";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2024.01.22"
chrM	7445	.	A	G	.	.	MITOMAP_Disease="SNHL";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.08"
chrM	7471	.	C	CC	.	.	MITOMAP_Disease="PEM AMDF Motor neuron disease-like";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.11.14"
chrM	7497	.	G	A	.	.	MITOMAP_Disease="MM EXIT";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.04.17"
chrM	7510	.	T	C	.	.	MITOMAP_Disease="SNHL";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.03.13"
chrM	7511	.	T	C	.	.	MITOMAP_Disease="SNHL/Deafness";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.11.30"
chrM	8306	.	T	C	.	.	MITOMAP_Disease="Severe adult-onset multisymptom myopathy Myoclonic epilepsy";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.10.24"
chrM	8313	.	G	A	.	.	MITOMAP_Disease="MNGIE-like Progressive mito cytopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.03.13"
chrM	8340	.	G	A	.	.	MITOMAP_Disease="Myopathy, Exercise Intolerance, CPEO-likechildhood epilepsy with SNHL & eye disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.05.22"
chrM	8344	rs118192098	A	G	.	.	MITOMAP_Disease="MERRF, Other - LD depressive mood disorder leukoencephalopathy HiCM lipomas";MITOMAP_Status="Cfrm P";MITOMAP_Update="2021.11.03"
chrM	8356	.	T	C	.	.	MITOMAP_Disease="MERRF";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.03.13"
chrM	8363	.	G	A	.	.	MITOMAP_Disease="MICM+DEAF MERRF Autism Leigh Syndrome Ataxia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.03.13"
chrM	8528	.	T	C	.	.	MITOMAP_Disease="Infantile cardiomyopathy hyperammonemia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.30"
chrM	8851	.	T	C	.	.	MITOMAP_Disease="BSN Leigh syndrome";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.04.13"
chrM	8969	.	G	A	.	.	MITOMAP_Disease="Mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) IgG nephropathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	8993	rs199476133	T	C	.	.	MITOMAP_Disease="NARP Leigh Disease MILS other";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	8993	rs199476133	T	G	.	.	MITOMAP_Disease="NARP Leigh Disease MILS other";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	9035	.	T	C	.	.	MITOMAP_Disease="Ataxia syndromes";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.30"
chrM	9155	.	A	G	.	.	MITOMAP_Disease="MIDD, renal insufficiency";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.30"
chrM	9176	.	T	C	.	.	MITOMAP_Disease="FBSN Leigh Disease Spinocerebellar Ataxia";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	9176	.	T	G	.	.	MITOMAP_Disease="Leigh Disease Spastic Paraplegia Spinocerebellar Ataxia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	9185	.	T	C	.	.	MITOMAP_Disease="Leigh Disease Ataxia syndromes NARP-like disease Episodic weakness and Charcot-Marie-Tooth";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.11"
chrM	9191	.	T	C	.	.	MITOMAP_Disease="Leigh Disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.03.24"
chrM	9204	.	ATA	A	.	.	MITOMAP_Disease="Encephalopathy Seizures Lacticacidemia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	10010	.	T	C	.	.	MITOMAP_Disease="PEM";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.11.14"
chrM	10158	.	T	C	.	.	MITOMAP_Disease="Leigh Disease MELAS";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	10191	.	T	C	.	.	MITOMAP_Disease="Leigh Disease ESOC";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.23"
chrM	10197	.	G	A	.	.	MITOMAP_Disease="Leigh Disease Dystonia Stroke LDYT";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.11"
chrM	10254	.	G	A	.	.	MITOMAP_Disease="Leigh Disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.10.23"
chrM	10663	.	T	C	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.30"
chrM	11777	.	C	A	.	.	MITOMAP_Disease="Leigh Disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	11778	rs199476112	G	A	.	.	MITOMAP_Disease="LHON Progressive Dystonia";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.11"
chrM	12147	.	G	A	.	.	MITOMAP_Disease="MERRF-MELAS Encephalopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.01.09"
chrM	12201	.	T	C	.	.	MITOMAP_Disease="Maternally inherited non-syndromic deafness";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.04.17"
chrM	12258	.	C	A	.	.	MITOMAP_Disease="DMDF RP+SNHL";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.03.28"
chrM	12276	.	G	A	.	.	MITOMAP_Disease="CPEO";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.11.30"
chrM	12294	.	G	A	.	.	MITOMAP_Disease="CPEO EXIT+Ophthalmoplegia";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.10.24"
chrM	12315	.	G	A	.	.	MITOMAP_Disease="CPEO KSS possible carotid atherosclerosis risk, trend toward myocardial infarction risk";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.11.30"
chrM	12316	.	G	A	.	.	MITOMAP_Disease="CPEO mitochondrial myopathy";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2023.02.27"
chrM	12424	.	AA	A	.	.	MITOMAP_Disease="Mitochondrial myopathy & renal failure";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.11.28"
chrM	12706	.	T	C	.	.	MITOMAP_Disease="Leigh Disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	13042	.	G	A	.	.	MITOMAP_Disease="Optic neuropathy/ retinopathy/ LD";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.06.30"
chrM	13051	.	G	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2023.05.23"
chrM	13094	.	T	C	.	.	MITOMAP_Disease="Ataxia+PEO MELAS, LD, LHON, myoclonus, fatigue";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.11"
chrM	13379	.	A	G	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	13513	.	G	A	.	.	MITOMAP_Disease="Leigh Disease MELAS LHON-MELAS Overlap Syndrome negative association w Carotid Atherosclerosis";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	13514	.	A	G	.	.	MITOMAP_Disease="Leigh Disease MELAS Ca2+ downregulation";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	14453	.	G	A	.	.	MITOMAP_Disease="MELAS Leigh Disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	14459	rs199476105	G	A	.	.	MITOMAP_Disease="LDYT Leigh Disease dystonia carotid atherosclerosis risk";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.04.13"
chrM	14482	.	C	A	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	14482	.	C	G	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.07.11"
chrM	14484	rs199476104	T	C	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.09.12"
chrM	14487	.	T	C	.	.	MITOMAP_Disease="Dystonia Leigh Disease ataxia ptosis epilepsy";MITOMAP_Status="Cfrm P";MITOMAP_Update="2022.08.08"
chrM	14495	.	A	G	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	14511	.	CTA	C	.	.	MITOMAP_Disease="EXIT w mild myopathy & hyperCKaemia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.12.21"
chrM	14568	.	C	T	.	.	MITOMAP_Disease="LHON";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.08.11"
chrM	14597	.	A	G	.	.	MITOMAP_Disease="LHON LS";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.08.14"
chrM	14674	.	T	C	.	.	MITOMAP_Disease="Reversible COX deficiency myopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.01.23"
chrM	14709	.	T	C	.	.	MITOMAP_Disease="MM+DMDF Encephalomyopathy Dementia+diabetes+ophthalmoplegia";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.01.23"
chrM	14710	.	G	A	.	.	MITOMAP_Disease="Encephalomyopathy + Retinopathy";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.12.15"
chrM	14786	.	ATTAA	A	.	.	MITOMAP_Disease="PD MELAS";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.12.11"
chrM	14849	.	T	C	.	.	MITOMAP_Disease="EXIT Septo-Optic Dysplasia";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.08.11"
chrM	15150	.	G	A	.	.	MITOMAP_Disease="EXIT";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2024.01.08"
chrM	15242	.	G	A	.	.	MITOMAP_Disease="Mitochondrial Encephalomyopathy";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2024.01.08"
chrM	15579	.	A	G	.	.	MITOMAP_Disease="Multisystem Disorder, EXIT";MITOMAP_Status="Cfrm VUS*";MITOMAP_Update="2022.07.11"
chrM	15923	.	A	G	.	.	MITOMAP_Disease="LIMM MERRF mito disease";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2023.06.26"
chrM	15990	.	C	T	.	.	MITOMAP_Disease="MM PEO";MITOMAP_Status="Cfrm LP";MITOMAP_Update="2022.02.13"
